… heart failure (CHF… failure, a reduction of endothelial NO release was associated with an
attenuated expression of eNOS [13, 14]. Data on basal production of NO in ischemic heart failure …

… therapies for heart failure with reduced ejection fraction (HFrEF), therapeutic efforts in the past
have failed … This review highlights the past, present, and future therapeutic approaches in …

Heart failure (HF) is a major health problem in Western countries. Despite significant progress
in pharmacological and device-based treatment, the disease burden imposed continues …

… Over the past several decades, important advances have been made in the treatment of
patients with heart failure (HF). Whereas in the past, the main goal of drug therapy was to relieve …

… decompensated heart failure (ADHF) is one of the leading admission diagnoses worldwide,
yet it is an entity with incompletely understood pathophysiology and limited therapeutic …

… in order to investigate the role of inflammation and to seek possible therapeutic approaches.
… systolic heart failure (Hellenic Heart Failure Study). Heart Vessels. 2009; 24: 22-26. 39. …

Heart failure (HF) is highlighted by its burdening symptom-limited exercise capacity and
recurrent hospitalizations. Despite substantial advances regarding disease-modifying drugs in …

… cardiac disease conditions, such as heart failure, contributing to the contractile dysfunction,
… and potential therapeutic approaches targeting nitric oxide signaling to treat heart disease. …

Anemia and iron deficiency are common in patients with heart failure (HF), and are associated
with worse symptoms and adverse outcomes in this population. Although the two can …

… Congestive heart failure is the leading cause of death in the Western world. Abnormal
intracellular calcium (Ca 2+ ) handling is central to the pathogenesis of heart failure because it …